TMVP1446/GS5, a novel peptide with improved metabolic stability relative to TMVP1446, targets VEGFR-3 for primary tumor and lymph node metastases detection in vivo
Advanced Interventional Materials · 2026-12 · 1 (1) · 100006
DOI: 10.1016/j.advim.2025.100006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Interventional Materials, 2026-12. Verfasst von Hanjie Xu und 7 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Xu, H., Zhang, D., Chen, Y., Zhao, C., Zhang, Y., Li, F., Xi, L., & Zhou, H. (2026). TMVP1446/GS5, a novel peptide with improved metabolic stability relative to TMVP1446, targets VEGFR-3 for primary tumor and lymph node metastases detection in vivo. Advanced Interventional Materials, 1(1), 100006. https://doi.org/10.1016/j.advim.2025.100006
Vancouver
Xu H, Zhang D, Chen Y, Zhao C, Zhang Y, Li F, et al. TMVP1446/GS5, a novel peptide with improved metabolic stability relative to TMVP1446, targets VEGFR-3 for primary tumor and lymph node metastases detection in vivo. Advanced Interventional Materials. 2026;1(1):100006. doi:10.1016/j.advim.2025.100006
BibTeX
@article{Xu2026,
author = {Xu, Hanjie and Zhang, Danya and Chen, Yuxin and Zhao, Can and Zhang, Yu and Li, Fei and Xi, Ling and Zhou, Hu},
title = {TMVP1446/GS5, a novel peptide with improved metabolic stability relative to TMVP1446, targets VEGFR-3 for primary tumor and lymph node metastases detection in vivo},
journal = {Advanced Interventional Materials},
year = {2026},
volume = {1},
number = {1},
pages = {100006},
doi = {10.1016/j.advim.2025.100006}
}
EUVIMED